These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37366804)

  • 1. Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.
    Amati F; Bindo F; Stainer A; Gramegna A; Mantero M; Nigro M; Bussini L; Bartoletti M; Blasi F; Aliberti S
    Adv Respir Med; 2023 May; 91(3):224-238. PubMed ID: 37366804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital.
    Ding H; Mang NS; Loomis J; Ortwine JK; Wei W; O'Connell EJ; Shah NJ; Prokesch BC
    Microbiol Spectr; 2024 Aug; 12(8):e0079224. PubMed ID: 39012119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study.
    Barreto JV; Dias CC; Cardoso T
    Eur J Intern Med; 2022 Feb; 96():66-73. PubMed ID: 34670681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choosing antibiotic therapy for severe community-acquired pneumonia.
    Martin-Loeches I; Garduno A; Povoa P; Nseir S
    Curr Opin Infect Dis; 2022 Apr; 35(2):133-139. PubMed ID: 35190510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 7. Community-acquired pneumonia: Trends in and research on drug resistance and advances in new antibiotics.
    Shen L; Wang L; Liu C; Shi S; Takahashi T; Wang T
    Biosci Trends; 2021 Nov; 15(5):266-275. PubMed ID: 34483225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Oliver MB; Fong K; Certain L; Spivak ES; Timbrook TT
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for prediction of drug-resistant pathogens and empiric antibiotic selection in community-acquired pneumonia.
    Gil R; Webb BJ
    Curr Opin Pulm Med; 2020 May; 26(3):249-259. PubMed ID: 32101906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftobiprole medocaril for the treatment of community-acquired pneumonia.
    Falcó V; Burgos J; Almirante B
    Expert Opin Pharmacother; 2018 Sep; 19(13):1503-1509. PubMed ID: 30198789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia.
    Rhodes NJ; Rohani R; Yarnold PR; Pawlowski AE; Malczynski M; Qi C; Sutton SH; Zembower TR; Wunderink RG
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0102322. PubMed ID: 36472425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study.
    Vallés J; Martin-Loeches I; Torres A; Diaz E; Seijas I; López MJ; Garro P; Castillo C; Garnacho-Montero J; Martin Mdel M; de la Torre MV; Olaechea P; Cilloniz C; Almirall J; García F; Jiménez R; Seoane E; Soriano C; Mesalles E; Posada P
    Intensive Care Med; 2014 Apr; 40(4):572-81. PubMed ID: 24638939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital.
    Simanjuntak RB; Lie KC; Rumende CM; Abdullah M; Shatri H; Koesnoe S; Nainggolan L; Rizka A
    Acta Med Indones; 2024 Jan; 56(1):55-62. PubMed ID: 38561875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin-resistant Staphylococcus aureus in community-acquired and health care-associated pneumonia: incidence, diagnosis, and treatment options.
    Dean N
    Hosp Pract (1995); 2010 Feb; 38(1):7-15. PubMed ID: 20469619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.
    Rhee C; Kadri SS; Dekker JP; Danner RL; Chen HC; Fram D; Zhang F; Wang R; Klompas M;
    JAMA Netw Open; 2020 Apr; 3(4):e202899. PubMed ID: 32297949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.
    Welte T; Kantecki M; Stone GG; Hammond J
    Int J Antimicrob Agents; 2019 Oct; 54(4):410-422. PubMed ID: 31404620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.